Healthcare provider profile · identity verified

Jeffrey Lineman

Family Practice · NATRONA HEIGHTS, PA · NPI 1275540403

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	366	108
Tramadol Hcl	Tramadol Hcl	188	30
Losartan Potassium	Losartan Potassium	179	50
Albuterol Sulfate Hfa	Albuterol Sulfate	159	30
Metoprolol Succinate	Metoprolol Succinate	154	38
Gabapentin	Gabapentin	143	32
Omeprazole	Omeprazole	140	45
Clonazepam	Clonazepam	135	21
Levothyroxine Sodium	Levothyroxine Sodium	134	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	22
Lisinopril	Lisinopril	127	36
Fluticasone Propionate	Fluticasone Propionate	119	43
Amlodipine Besylate	Amlodipine Besylate	105	29
Metformin Hcl	Metformin Hcl	104	33
Pantoprazole Sodium	Pantoprazole Sodium	101	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	99	29
Ozempic	Semaglutide	99	18
Doxepin Hcl	Doxepin Hcl	93	27
Rosuvastatin Calcium	Rosuvastatin Calcium	84	26
Duloxetine Hcl	Duloxetine Hcl	81	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	80	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	79	23
Pravastatin Sodium	Pravastatin Sodium	74	19
Eliquis	Apixaban	68	11
Metformin Hcl Er	Metformin Hcl	67	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	suppressed
Prednisone	Prednisone	66	37
Bupropion Hcl Sr	Bupropion Hcl	63	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	11
Spironolactone	Spironolactone	61	14
Furosemide	Furosemide	60	17
Ropinirole Hcl	Ropinirole Hcl	60	14
Montelukast Sodium	Montelukast Sodium	59	16
Clopidogrel	Clopidogrel Bisulfate	58	14
Alprazolam	Alprazolam	55	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	55	suppressed
Ibuprofen	Ibuprofen	55	14
Hydrochlorothiazide	Hydrochlorothiazide	54	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	52	14
Jardiance	Empagliflozin	52	15
Mounjaro	Tirzepatide	51	suppressed
Famotidine	Famotidine	49	15
Lorazepam	Lorazepam	49	11
Warfarin Sodium	Warfarin Sodium	48	suppressed
Alendronate Sodium	Alendronate Sodium	42	12
Buspirone Hcl	Buspirone Hcl	42	11
Simvastatin	Simvastatin	39	12
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Aripiprazole	Aripiprazole	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	35	suppressed
Glipizide Er	Glipizide	35	12
Ezetimibe	Ezetimibe	33	suppressed
Meloxicam	Meloxicam	32	15
Topiramate	Topiramate	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Allopurinol	Allopurinol	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	suppressed
Terbinafine Hcl	Terbinafine Hcl	30	12
Metoprolol Tartrate	Metoprolol Tartrate	29	suppressed
Ondansetron Odt	Ondansetron	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Celecoxib	Celecoxib	27	11
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	17
Carvedilol	Carvedilol	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	24	suppressed
Colestipol Hcl	Colestipol Hcl	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	21	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Dexamethasone	Dexamethasone	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Loperamide	Loperamide Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Bethanechol Chloride	Bethanechol Chloride	16	suppressed
Erythromycin Ethylsuccinate	Erythromycin Ethylsuccinate	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Azithromycin	Azithromycin	14	11
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Primidone	Primidone	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Dutasteride	Dutasteride	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Bumetanide	Bumetanide	11	suppressed
Colchicine	Colchicine	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Rexulti	Brexpiprazole	11	suppressed
Savella	Milnacipran Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error